After completing her thesis project on the role of Th17-like cells in Inflammatory Bowel Disease at Erasmus University Rotterdam: Maya chose to pursue her interest in pathogenic T cells as a cause for autoimmune disease, leading her to the Tree Group. Here, as a Research Assistant, she helps coordinate, process, and perform experiments on clinical samples from ongoing immunotherapy trials for Type-1 Diabetes (T1D). She aims to contribute to the development of new immune-modulating therapies - treating or preventing T1D worldwide.